American Pharma and Biotech Advancements in Drug Safety Summit
World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under the Why Summits Future of Pharmacovigilance World Tour
key information
- Location: Holiday Inn Philadelphia Airport Stadium Area (Formerly Radisson Hotel Philadelphia) 2033 Penrose Avenue Philadelphia, PA 19145 United States
- Part of the Pharmacovigilance World Tour
- September 13-14, 2023
- 9:00 - 17:30 Local Time
OUR CONFERENCE PROGRAM
KEY TOPICS
- Pharmacovigilance of advanced therapies
- Stepping up the global game in PV reporting strategies
- Outcomes of rising public awareness: social media and mobile apps in pharmacovigilance E2B(R3) implementation, are you truly compliant? EudraVigilance and FDA case studies
- Translating genomics into improved patient outcomes
- Transparency and Patient Engagement
- New Directions in Benefit Risk Assessments
- Navigating PV disruption and skills required to survive
- The Global Regulatory Environment and Aspects of Harmonization
- The vision of outsourcing in the pharma industry: current and future trends
- Drug safety in oncology: consequences of accelerated approvals in Europe
- An innovative roadmap to the adoption of marketed pharmacovigilance automation and Artificial Intelligence (AI) with a focus on efficiency ROI
- PV audit storytelling session – Inspection insights from a global perspective
- Enhancing PV compliance in a joint partnership for a product marketed in differently regulated markets
Who will attend
- 25% Industry consultants, Academia & Solutions and Software providers
- 75% Big & SME Pharma and Biotech companies
2023 Speakers
Angela Overton
Prevail InfoWorks
Lina Ogbu
Arcus Biosciences
Dr. Gerald Klein
MedSurgPI (Prevail InfoWorks)
Dennis Vargo
Julie Miller
Sanofi
Sandra Raff
Ultragenyx Pharmaceuticals
Michael Glaser
GSK
Vanessa Roknic
Novo Nordisk
Oleg Zvenigorodsky
Jazz Pharmaceuticals
Kapil Bhutada
Inozyme Pharma
Sarah Bradley
Blue Spark Technologies
Graeme Ladds
Pharsafer
Raidah Salem
Almirall
Vincent D´Esposito
Otsuka Pharmaceutical Companies
Dawn Mucci
Jazz Pharmaceuticals
Kidus Mengistu
Y-mAbs Therapeutics
Anthony Bailey
Zoetis
REGISTRATION
Conference
Ticket | September 13-14, 2023-
Access to All Conference Sessions of the Future of Pharmacovigilance Philadelphia Summit
-
Access to Post Conference Networking
-
Conference Materials
-
Includes Coffee Breaks, Snacks and Refreshments, Seated Lunch
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
event partners
Prevail InfoWorks is a global full service CRO that uniquely combines clinical expertise and engineering prowess. For over a decade, we have been biotech’s and biopharma’s one-stop-shop for the most innovative, complete, and flexible clinical trial software solutions. Prevail’s Single Interface® provides study teams with a single sign-on for real-time reporting, dashboard analytics and process management derived from its automated integration of all your study data sources and systems (EDC, IRT, labs, imaging, EEG, ePRO/eCOA, wearables). For pharmacovigilance teams, those systems can include Prevail’s Safety Data Management System or any other SDMS. By seamlessly integrating our SDMS with all other study data, patient safety oversight, signal detection and reporting is easier and more robust; benefiting the patients, study, and you.
Founded in 2003 by Dr Graeme Ladds, PharSafer® is a specialist Contract Research Organisation (CRO) in Global Clinical and Post Marketing Drug Safety, and Medical Services, with a wealth of experience in Pharmacovigilance, Auditing and Medical Affairs – and the various, numerous and extensive legal safety/medical obligations for licence holders to comply with – as well as Regulatory Strategy for the best methods for obtaining scientific advice concerning licence submissions and approvals.
Our ability to offer first-class services in Pharmacovigilance, Regulatory Strategy, Training, Auditing, Medical Affairs and IT Informatics means that, for many clients, we operate as their Pharmacovigilance and Medical Departments, guiding them through the labyrinth of drug safety and medical legislation – all in the interests of ensuring patient safety and client compliance.
Genpact (NYSE: G) is a global professional services firm delivering the outcomes that transform our clients’ businesses and shape their future. We’re guided by our real-world experience redesigning and running thousands of processes for hundreds of global companies. Our clients – including many in the Fortune Global 500 – partner with us for our unique ability to combine deep industry and functional expertise, leading talent, and proven methodologies to drive collaborative innovation that turns insights into action and delivers outcomes at scale. We create lasting competitive advantages for our clients and their customers, running digitally enabled operations and applying our Data-Tech-AI services to design, build, and transform their businesses. And we do it all with purpose. From New York to New Delhi and more than 30 countries in between, our 115,000+ team is passionate in its relentless pursuit of a world that works better for people.
Twitter: https://twitter.com/genpact
Facebook: https://www.facebook.com/ProudToBeGenpact/
Instagram: https://www.instagram.com/genpact_careers/
YouTube: https://www.youtube.com/@GenpactGlobal